Medical Store Booked For Overpricing In Rewari

CHANDIGARH : A team of Food and Drug Administration on Sunday conducted a raid and seized medicines being sold at higher prices than MRP in Haryana’s Rewari district.

The raid was conducted on the instruction of the Haryana health and family welfare minister, Anil Vij.

Giving information in this regard, a spokesperson of the Food and Drug Administration said that acting on the tip-off, the Drug Control Officer, Rewari conducted a decoy operation at M/s Vinayak Medical Store where Sukhbir Singh, owner of the medical store was found selling cough syrup containing Codeine Phosphate at Rs 200 and capsule strip containing Tramadol Hydrochloride at Rs 100 without prescription by a registered pharmacist.

During the raid, Sukhbir could not produce the Retail Sale Drug License (RSDL) for the sale of these medicinal narcotic products, which he is selling at a higher price than the MRP. Notably, the MRP of the cough syrup is Rs 143 and the capsule strip is Rs 57.

The spokesman said that following the raid, 672 capsules containing tramadol and 7 syrups containing codeine phosphate were recovered. This medical store has been sealed and FIR against Sukhbir Singh and others under sections of NDPS Act and Essential Commodities Act 1955 and DPCO 2013 has been registered at police station, Kasola, Rewari.

He said that strict action will be taken against drug peddlers who indulged in such illicit practices.

  • Related Posts

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’